Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
European Journal of Clinical Investigation|February 20, 2002
Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?A Becker, V W M van Hinsbergh, A Jager, et al.
BMC Medical Research Methodology|December 3, 2020
COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi studyL B Mokkink, M Boers, C P M van der Vleuten, et al.
The British Journal of Ophthalmology|July 1, 1997
Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995A C Moll, D J Kuik, L M Bouter, et al.
Diabetologia|June 16, 2000
Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn StudyJ Gerritsen, J M Dekker, B J TenVoorde, et al.
The Cochrane Database of Systematic Reviews|April 20, 2007
Traction for low-back pain with or without sciaticaJ A Clarke, M W van Tulder, S E I Blomberg, et al.
Journal of Internal Medicine|January 5, 2000
Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: the Hoorn StudyE K Hoogeveen, P J Kostense, G D Valk, et al.
European Journal of Clinical Nutrition|September 1, 2006
Dietary polyunsaturated fat intake is associated with low-density lipoprotein size, but not with susceptibility to oxidation in subjects with impaired glucose metabolism and type II diabetes: the Hoorn studyG Bos, M C Poortvliet, P G Scheffer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 19, 2018
COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi studyC B Terwee, C A C Prinsen, A Chiarotto, et al.
European Journal of Clinical Investigation|January 22, 2003
Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn StudyA M W Spijkerman, J M Dekker, G Nijpels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn StudyA Jager, V W van Hinsbergh, P J Kostense, et al.
Pageof 30